The functional aspects of the peripheral blood lymphocytes from 6 patients with primary selective IgM deficiency (slgMD) were analyzed to elucidate its pathogenesis. Internal Medicine 31: 866-870, 1992) 
Introduction

Materials and Methods
Primary selective IgM deficiency (slgMD) has been reported to be rare, with an incidence of less than 0.03% among the general population (1) and 1% in hospitalized patients (2). But the recent availability of immunological analyses has facilitated further testing which has indicated that this disorder is more common than previously thought. Patients with malignant neoplasias (3, 4), autoimmune diseases (5, 6), infections (7) or those given immunosuppressive agents may develop slgMD; the incidence of slgMD is about 2% (8). Most patients with slgMD typically suffer from severe refractory or recurrent infections, however about 20% of the patients have no symptoms (8). Of these asymptomatic patients, most are adults and their low serum level of IgM is found incidentally during hospitalization for other unrelated diseases. The pathogenetic abnormalities in slgMD have been shown to be in B cell dysfunction (9) or T cell abnormality (10, ll) as analyzed by in vitro immunological examinations.
Here, we report six adult patients with primary slgMD. The surface antigens on peripheral lymphocytes were analyzed and B cell and T cell function was examined in detail. The pathogenesis of this disease is discussed.
Patients. All patients (5 males and 1 female; mean age 43 years; range 22-57) had a persistently low level of serum IgM. None of the patients had hematological diseases, autoimmune diseases, renal dysfunction or had received immunosuppressive agents or other drugs such as gold or salazosulfapyridine. Also the cell count of peripheral lymphocytes of each patient was within normal limits. All serum samples were drawn during infection-free periods. Six healthy subjects with a normal level of serum IgM were used as controls in this study. Measurement of serum immunoglobulins. Serum IgM, IgG, IgA and IgD were measured by a standard radial immunodiffusion method and serum IgE was measured by competitive radioimmunoassay. Cell preparation. Mononuclear cells (MNC) from heparinized peripheral venous blood of the patients and healthy controls were isolated by centrifugation on Ficoll Conray (Pharmacia Fine Chemicals, Piscataway, NJ) density gradient. MNC were separated into T cells and non-T cells by a rosetting method with s-(2-aminoethyl) isothiouronium bromide hydrobromide (AET: Sigma Chemical Co., St. Louis, MO)-treated sheep red blood cells (RBC). Then, non-T cells were incubated on plastic dishes for 2 hours at 37°C and nonadherent cells were harvested. Purified T or B cells (1 x 106 cells/ml) were suspended in RPMI 1640 medium (Nissui Pharmaceutical Co., Japan) containing 10% fetal calf serum (FCS: M.A. Bioproducts, Inc., Walkersville, MD), 2mM L-glutamine, 5 x lO~5 M 2-mercaptoethanol, and anti biotics. In some experiments, T and B cells were cultured together at a 1: 1 ratio; mixed lymphocyte culture (MLC). Analysis of cell surface antigens. T cells (1 x 106 cells/ml) were identified with fluorescein isothiocyanate (FITC) conjugated with each monoclonal antibody to cell surface molecules, such as cluster of differentiation (CD)2, CD4, and CD8 (Ortho Diagnostic Systems Inc., Raritan, NJ). B cells were also identified with FITC-labelled monoclonal antibody to CD20 (Coulter Immunology, Hialeah, FL), and FITC-labelled F(ab')2 fragments of affinity-purified goat anti-human IgM, IgA, IgG or IgD. Cells were analyzed by flow microfluorometry using Ortho Spectrum III (Ortho Diagnostic Systems Inc., Raritan, NJ). we used partially purified culture supernatants of an EB-virus transformed B cell line, CESS, kindly donated by Dr. K. Yoshizaki (12). The final concentration of BCDF used in this study was 1U/ml. Inhibition of suppressor T cell function. In some experiments, purified T cells were exposed to 50 /ig/ml of mitomycin C (MMC) for 30 minutes at 37°C to inhibit the suppressor function as previously described (13, 14) . Immunoglobulin synthesis. Purified B cells were cultured at 1 x 106 cells/ml with 0.0025% of SAC and lu/ml of BCDF. In some experiments, B cells (2 X 105 cells/well) were cocultured with T cells (2 X 105 cells/ well) which were treated with or without MMC for 30 minutes in the presence of 1% of pokeweed mitogen (PWM: GIBCO, Grand Island, NY). They were incu bated in 96-well microtiter plates for 6 days, and immu noglobulin (Ig)-producing cells were enumerated by a reverse plaque assay with protein A (Sigma Chemical Co., St. Louis, MO) as previously reported (15). Briefly, after 6 days an appropriate dilution of cultured cells was added in duplicate to a reaction mixture containing a 10% suspension of protein A-coupled sheep RBC and 0.6% agarose. The mixture was spread onto an agarose coated glass slide and these slides were flooded with a 1:100 dilution of rabbit anti-human IgM, IgG or IgA antiserum and then incubated at 37°C. This was followed by flooding with a 1:25 dilution of guinea pig complement and further incubation. The results are shown as the arithmetic mean number of plaque-forming cells (PFC). Results Table 1 , all patients had a low level of serum IgM, which was not normalized after they had been clinically improved. The serum levels of IgG and IgA were normal in all patients, but two patients (TN & KT) had a remarkably high level of serum IgE. Four had infections and two had diabetes mellitus and one was asymptomatic (Table 1) .
Serum Ig levels As shown in
Cell surface markers on lymphocytes Analysis of surface antigens on peripheral lymphocytes revealed no difference in the distribution of CD20 and CD2 positive cells between patients and controls. And surface IgM positive B cells were normal in all patients. However, there was a significant increase in the percent age of CD4 positive (CD4+) cells (910 ± 147 cells/ml, p<0.01) and a reduction of the percentage of CD8 positive (CD8+) cells (293 ±53 cells/ml, p<0.05) in the peripheral blood of patients compared with that of controls ( Table 2) . Proliferative response The proliferative response of peripheral T and B cells stimulated with mitogens is shown in Fig. 1 . Treat ment with PHA-P or Con A induced proliferation of patient T cells at almost the same level as that of con trols, but the proliferative response of patient B cells to SAC was markedly lower (Fig. 1) than that of controls (10,978 ± 1,249cpm; mean ±SD). T cell-dependent Ig production We examined the capacity of Ig production by patient B cells in the presence of PWM (1%). These B cells produced only one-third to one-tenth of the control level of IgM when cultured with autologous T cells (Fig. 2 , open column of R of each patient), and one fourth to two-thirds of the control level of IgM when cultured with normal T cells (Fig. 2, open On the other hand, IgM production by the control B cells cocultured with patient T cells was similar to the control (Fig. 2 , open column of P of each patient).
IgM production in the absence of suppressor T cells To further investigate the failure of IgM production by patient B cells, the suppressor function of CD8+ T cells was inhibited by treatment with MMC as described in detail elsewhere (13, 14) . Interestingly, the patient T cells treated with MMC induced much more IgM secretion by control B cells than the untreated patient T cells (Fig. 2 , closed column ofP of patients 1, 2, 4 and 5). This result suggests that the helper function of T cells in patients with slgMD may possess a higher activity than that of controls, because of the low level of serum IgM.
T cell-independent Ig production The next examination was designed to investigate B cell function without the influence of T cells. As shown in Fig. 3 , patient B cells failed to secrete a comparable amount of IgM after stimulation with SAC and BCDF. In contrast, patient B cells did produce a significant amount of IgG and IgA under the same conditions (Fig. 3) . This result suggests that there may be a selective defect in patient B cells during B cell maturation into IgM-producing cells.
Discussion
We report here the in vitro functional analysis of the peripheral blood lymphocytes from six patients with primary slgMD. Surface IgM positive B cells were present at a normal level as previously reported (9, ll). In contrast, there was a significant increase in the per centage of CD4+ cells (p <0.01) and a reduction in the percentage of CD8+ positive cells (p < 0.05). Although an increase of the CD4/CD8 ratio is reported in many diseases such as rheumatoid arthritis and autoimmune hemolytic anemia (16), no patients examined in this study had these diseases. There might be a possibility that an increase in CD4+ T cells is the result of hyper function of helper T cells to restore a low level of serum IgM, because patient T cells treated with MMC induced an increase in the IgM production by normal B cells (Fig. 2) . Interestingly, two patients had a remarkable elevation of serum IgE levels (patient TN and KT). There are some reports of cases with an elevated serum IgE level (17-19). These patients simultaneously had chronic or atopic dermatitis and recurrent skin abscess caused by Staphylococcus aureus. The B cells of the present patients showed a significantly low proliferative response to SAC. Thus, a high level of serum IgE may be due to chronic infection or hyper-reactivity to this bacterium (20) due to a lack of antibody production. We showed that the defect of IgM production of patients with slgMD was the result of the failure of B cell differentiation into IgM secretion as reported previously (9, 21) . In contrast to these findings, there are some reports which propose that a lack of helper function of CD4+ T cells (18) or excessive activity of CD8+ T cells (ll) is the primary factor in slgMD. Thus, the pathogenesis of this disease may be heterogenous as well as selective IgA deficiency (22). However, there has been no report of detailed analyses of B cell function in slgMD without T cell help. In the present study, we used SAC and BCDF to stimulate B cells to produce Ig without the influence of T cells. Patient B cells did not secrete a significant amount of IgM when treated with SAC and BCDF, although they produced a marked quantity of IgG and IgA under the same conditions as shown in Figure 3 . From the present findings, the patho genesis of slgMD may be an intrinsic B cell abnormality during maturation into IgM-secreting cells. Although the proliferative response of patient B cells to SAC was significantly decreased compared with that of controls ( Fig. 1) , it seems unlikely that this hypo-responsiveness caused the defect of IgM production because a sufficient amount of IgG and IgA were produced after treatment with SAC and BCDF (Fig. 3) .
Patients with slgMD are reported to have a defect in IgM antibody production to some antigens and to have a high titer of IgG isohemagglutinins as substitutes for IgM antibody due to low IgM production (17 
